The Genetics of Ovarian Cancer

References

• Weinberg R A. The genetic origins of human cancer. Cancer 1988; 61: 1963–1968
   PubMed Web of Science ®Google Scholar
• Sager R. Tumor suppressor genes: The puzzle and the promise. Science 1989; 246: 1406–1412
   PubMed Web of Science ®Google Scholar
• Bishop J M. Molecular themes in carcinogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Trent J M, Kaneka Y, Mitelman F. Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet 1989; 51: 533–562
   PubMedGoogle Scholar
• Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249–270
   PubMed Web of Science ®Google Scholar
• Marshall C J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Doll R, Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1193–1308
   Google Scholar
• Ponder B AJ. Inherited predisposition to cancer. Trends Genet 1990; 6: 213–218
   PubMed Web of Science ®Google Scholar
• Kimbrough RA, Jr. Coincident carcinoma of the ovary in twins. Am J Obstet Gynecol 1929; 18: 148–149
   Google Scholar
• Liber A F. Ovarian cancer in mother and five daughters. Arch Pathol 1950; 49: 280–290
   Google Scholar
• Graham J B, Graham R M, Schueller E F. Preclinical detection of ovarian cancer. Cancer 1964; 17: 1414–1432
   PubMed Web of Science ®Google Scholar
• Lewis A CW, Davison B CC. Familial ovarian cancer. Lancet 1969; 2: 235–237
   PubMed Web of Science ®Google Scholar
• Li F P, Rapoport A H, Fraumeni J F. Familial ovarian carcinoma. J Am Med Assoc 1970; 214: 1559–1561
   Web of Science ®Google Scholar
• Molloy W B. Identical ovarian malignant disease in two sisters. Aust NZ J Obstet Gynecol 1970; 10: 256–258
   PubMed Web of Science ®Google Scholar
• McCrann D J, Marchant D J, Bardawil W A. Ovarian carcinoma in three teen-age siblings. Obstet Gynecol 1974; 43: 132–137
   PubMed Web of Science ®Google Scholar
• Fraumeni J F, Grundy G W, Creagan E T. Six families prone to ovarian cancer. Cancer 1975; 36: 364–369
   PubMed Web of Science ®Google Scholar
• Thor L, Persson B H, Kjessler B. Familial ovarian carcinoma. Upsala J Med Sci 1976; 81: 189–191
   PubMed Web of Science ®Google Scholar
• Skinner J L, Oats J JN, Symonds E M. Familial ovarian carcinoma. J R Coll Gen Pract 1977; 27: 169–170
   PubMedGoogle Scholar
• Nevo S. Familial ovarian carcinoma. A problem in genetic counseling. Clin Genet 1978; 14: 219–222
   PubMed Web of Science ®Google Scholar
• Lurain J R, Piver M S. Familial ovarian cancer. Gynecol Oncol 1979; 8: 185–192
   PubMed Web of Science ®Google Scholar
• Philipp E E. Familial carcinoma of the ovary: Case report. Br J Obstet Gynecol 1979; 86: 152–153
   PubMedGoogle Scholar
• Matheson J AB, Matheson H, Anderson S A. Familial ovarian cancer. How rare is it. J R Coll Gen Pract 1981; 31: 743–745
   PubMedGoogle Scholar
• Tucker M HM, Fryer J A, Saunders D M. Ovarian carcinoma in identical twins. Aust NZ J Obstet Gynecol 1982; 22: 113–115
   PubMed Web of Science ®Google Scholar
• Tobackman J K, Tucker M A, Kase R. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer prone families. Lancet 1982; 2: 795–797
   PubMed Web of Science ®Google Scholar
• Borrie P M, Thomson J D. Familial ovarian carcinoma. NZ Med J 1982; 95: 147–148
   PubMedGoogle Scholar
• Franceschi S, LaVecchia C, Mangioni C. Familial ovarian cancer: Eight more families. Gynecol Oncol 1982; 13: 31–36
   PubMed Web of Science ®Google Scholar
• Lynch H T, Albano W M, Lynch J F. Surveillance and management of patients at high genetic risk for ovarian carcinoma. Obstet Gynecol 1982; 59: 589–596
   PubMed Web of Science ®Google Scholar
• Piver M S, Barlow J J, Sawyer D M. Familial ovarian cancer: Increasing in frequency. Obstet Gynecol 1982; 60: 397–400
   PubMed Web of Science ®Google Scholar
• Chudina A P, Akulenko L V, Pichugina M N. An ovarian cancer family: clinical and cytogenetic data. Cancer Genet Cell Genet 1983; 10: 143–150
   PubMed Web of Science ®Google Scholar
• Piver M S, Mettlin C J, Tsukada Y. Familial ovarian cancer registry. Obstet Gynecol 1984; 64: 195–199
   PubMed Web of Science ®Google Scholar
• Lynch H T, Schuelke G, Wells I C. Hereditary ovarian carcinoma. Cancer 1985; 55: 410–415
   PubMed Web of Science ®Google Scholar
• Chen K TK, Schooley J L, Flan M S. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol 1985; 66: 93S–94S
   PubMed Web of Science ®Google Scholar
• Ponder B AJ, Easton D F, Peto J. Risk of ovarian cancer associated with a family history: Preliminary report of the OPCS study. Ovarian Cancer: Biological and Therapeutic Challenges, F Sharp, WP Mason, RE Leake. Chapman and Hall, London 1990; 3–6
   Google Scholar
• Menczer J, Ben-Baruch G. Familial ovarian cancer in Israeli Jewish women. Obstet Gynecol 1991; 77: 276–277
   PubMed Web of Science ®Google Scholar
• Lynch H T, Krush A J. Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 1971; 133: 644–648
   PubMedGoogle Scholar
• Lynch H T, Guirgis H A, Albert S. Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 1974; 138: 717–724
   PubMedGoogle Scholar
• Lynch H T, Harris R E, Guirgis H A. Familial association of breast/ovarian carcinoma. Cancer 1978; 41: 1543–1549
   PubMed Web of Science ®Google Scholar
• Go R C, King M C, Bailey-Wilson J. Genetic epidemiology of breast cancer and associated cancers in high risk families. 1. Segregation analysis. J Natl Cancer Inst 1983; 71: 455–461
   PubMed Web of Science ®Google Scholar
• Lynch H T, Bewtra C, Lynch J T. Familial ovarian carcinoma. Am J Med 1986; 81: 1073–1076
   PubMed Web of Science ®Google Scholar
• Blanchet-Bardon C, Nazzaro V, Chevrant-Breton J. Hereditary epidermolytic palmoplanar keratoderma associated with breast and ovarian cancer in a large kindred. Br J Dermatol 1987; 117: 363–370
   PubMed Web of Science ®Google Scholar
• Ferrell R E, Anderson A, Chidambaram A. A genetic linkage study of familial breast-ovarian cancer. Cancer Genet Cytogenet 1989; 38: 241–248
   PubMed Web of Science ®Google Scholar
• Lynch H T, Lynch P M. Tumor variation in the cancer family syndrome: Ovarian cancer. Am J Surg 1979; 138: 439–442
   PubMed Web of Science ®Google Scholar
• Lynch H T, Albano W, Black. Familial excess of cancer of the ovary and other anatomic sites. JAMA 1981; 245: 261–264
   PubMed Web of Science ®Google Scholar
• Hildreth N G, Kelsey J L, LiVolsi V A. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114: 398–405
   PubMed Web of Science ®Google Scholar
• Cramer D W, Hutchinson G B, Welch W R. Determinants of ovarian cancer risk. 1. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711–716
   PubMed Web of Science ®Google Scholar
• Schildkraut J M, Thompson W D. Familial ovarian cancer: A population based case-control study. Am J Epidemiol 1988; 128: 456–466
   PubMed Web of Science ®Google Scholar
• Mori M, Harabuchi I, Miyake H. Reproductive, genetic and dietary risk factors for ovarian cancer. Am J Epidemiol 1988; 128: 771–777
   PubMed Web of Science ®Google Scholar
• Koch M, Gaedks H, Jenkins H. Family history of ovarian cancer patients: A case-control study. Int J Epidemiol 1989; 18: 782–785
   PubMed Web of Science ®Google Scholar
• Schildkraut J M, Risch N, Thompson W D. Evaluating, genetic association among ovarian, breast, and endometrial cancer: Evidence for a breast/ovarian cancer relationship. Am J Human Genet 1989; 45: 521–529
   PubMed Web of Science ®Google Scholar
• Schildkraut J M, Thompson W D. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol 1988; 5: 355–367
   PubMed Web of Science ®Google Scholar
• Schoenberg B S, Greenberg R A, Eisenberg H. - Occurrence of certain multiple primary cancers in females. J Natl Cancer Inst 1969; 43: 15–32
   PubMed Web of Science ®Google Scholar
• Schottenfeld D, Berg J D. Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 1971; 46: 161–170
   PubMed Web of Science ®Google Scholar
• Lynch H T, Conway T, Lynch J. Hereditary ovarian cancer. Ovarian Cancer: Biological and Therapeutic Challenges, F Sharp, WP Mason, RE Leake. Chapman and Hall, London 1990; 7–19
   Google Scholar
• Roweley J D. Molecular cytogenetics: Rosetta stone for understanding cancer–twenty-ninth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 3816–3825
   PubMed Web of Science ®Google Scholar
• Testa J R. Chromosome translocations in human cancer. Cell Growth Different 1990; 1: 97–101
   PubMedGoogle Scholar
• Atkin N B, Pickthall V J. Chromosomes 1 in 14 ovarian cancers. Heterochromatin variants and structural changes. Human Genet 1977; 38: 25–33
   PubMed Web of Science ®Google Scholar
• Van der Rief-Fox M F, Retief A E, Van Niekeik W A. Chromosome changes in 17 human neoplasms studied with banding. Cancer 1979; 44: 2108–2119
   PubMed Web of Science ®Google Scholar
• Wake N, Hreschshyn M, Piver M S. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res 1980; 40: 4512–4518
   PubMed Web of Science ®Google Scholar
• Atkin N B, Baker M C. Specific chromosome change in ovarian cancer. Cancer Genet Cytogenet 1981; 3: 275–276
   PubMed Web of Science ®Google Scholar
• Trent J M, Salmon S E. Karyotypic analysis of human ovarian carcinoma cells dones in short term agar culture. Cancer Genet Cytogenet 1981; 3: 279–291
   PubMed Web of Science ®Google Scholar
• Kusyk C J, Seski J C, Medlin W V. Progressive chromosome changes associated with different sites of one ovarian carcinoma. J Natl Cancer Inst 1981; 66: 1021–1025
   PubMed Web of Science ®Google Scholar
• Whang-Peng J, Knutsen T, Douglass E C. Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 1984; 11: 91–106
   PubMed Web of Science ®Google Scholar
• Panani A, Ferti-Passantonopoulou A. Common marker chromosomes in ovarian cancer. Cancer Genet Cytogenet 1985; 16: 65–71
   PubMed Web of Science ®Google Scholar
• DeBlois M C, Boyer P, Benard J. Anomalies chromsomiques dans deux cas de cancers humains ovariens. C R Acad Sc Paris 1986; 302: 81–86
   PubMedGoogle Scholar
• Smith A, Roberts C, Van Haaften-Day C. Cytogenetic findings in cell lines derived from four ovarian carcinomas. Cancer Genet Cytogenet 1987; 24: 231–242
   PubMed Web of Science ®Google Scholar
• Atkin N B, Baker M C. Abnormal chromosomes including small metacentrics in 14 ovarian cancels. Cancer Genet Cytogenet 1987; 26: 355–361
   PubMed Web of Science ®Google Scholar
• Tanaka K, Boice C R, Testa J F. Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 1989; 43: 1–14
   PubMed Web of Science ®Google Scholar
• Sheer D, Sheppard D M, Gorman P A. Cytogenetic analysis of four human ovarian carcinoma cell lines. Cancer Genet Cytogenet 1987; 26: 339–349
   PubMed Web of Science ®Google Scholar
• Pejovic T, Heim S, Mandahl N. Consistent occurrence of a 19p+ marker chromosome and loss of lip material in ovarian seropapillary cystadenccarcinomas. Genes Chromosomes Cancer 1989; 1: 167–171
   PubMed Web of Science ®Google Scholar
• Roberts C G, Tattersall M HN. Cytogenetic study of solid ovarian tumors. Cancer Genet Cytogenet 1990; 48: 243–253
   PubMed Web of Science ®Google Scholar
• Franke U. Retinoblastoma and chromosome 13. Birth Defects 1978; 12: 131–137
   Google Scholar
• Franke U, Holmes L B, Atkins L. Aniridia-Wiims tumor association: evidence for a specific deletion of llpl3. Cytogenet Cell Genet 1979; 24: 185–192
   PubMedGoogle Scholar
• Hansen M F, Cavanee W K. Genetics of cancer predisposition. Cancer Res 1987; 47: 5518–5527
   PubMed Web of Science ®Google Scholar
• Atkin N B. Chromosome 1 heteromorphism inpatients with malignant disease: a constitutional marker for a high risk group. Br Med J 1977; 1: 358
   PubMed Web of Science ®Google Scholar
• Kivi S, Mikelsaar A V. C-Band polymorphisms in lymphocytes of patients with ovarian or breast adenocarcinoma. Cancer Genet Cytogenet 1987; 28: 77–85
   PubMed Web of Science ®Google Scholar
• DeMas R. Genetic Concepts and Neoplasia. Twenty-Third Annual Symposium on Fundamental Cancer Research, 1969. William and Wilkins, Baltimore 1970; 105–106
   Google Scholar
• Knudson A G. Mutation and cancer: statistical study of retinoblasoma. Proc Natl Acad Sci (USA) 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Lee J H, Kavanagh J J, Wharton J T. Allele loss of c-Ha-ras 1 locus in human ovarian cancer. Cancer Res 1989; 49: 120–1222
   Google Scholar
• Lee J H, Kavanagh J J, Wildrick D M. Frequent loss of heterozygosity of chromosome 6q, 11 and 17 in human ovarian carcinomas. Cancer Res 1990; 50: 2724–2728
   PubMed Web of Science ®Google Scholar
• Ehlen T, Dubeau L. Loss of heterozygosity on chromosomal segments 3p, 6q and 1 lp in human ovarian carcinomas. Oncogene 1990; 5: 219–223
   PubMed Web of Science ®Google Scholar
• Russell S EH, Hickey G I, Lowry W S. Allele loss from chromosome 17 in ovarian cancer. Oncogene 1990; 5: 1581–1583
   PubMed Web of Science ®Google Scholar
• Eccles D M, Cranston G, Steel C M. Allele loss on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 1990; 5: 1599–1601
   PubMed Web of Science ®Google Scholar
• Eiberg H, Mohr J, Nielsen L S. Linkage of the plasma a-L-fucosidase (FUCA2) and the plasminogen (PLG) system. Clin Genet 1984; 26: 23–29
   PubMed Web of Science ®Google Scholar
• Murray J C, Bectow H, Donovan M. Linkage disequilibrium of plasminogen polymorphisms and assignment of the gene to human chromosome 6q26–6q27. Am J Hum Genet 1987; 40: 338–350
   PubMed Web of Science ®Google Scholar
• Olaisen B, Sakaguchi A Y, Naylor S L. Report of the Committee on the Genetic Constitution of Chromosomes 5 and 6. Cytogenet Cell Genet 1987; 46: 147–169
   PubMedGoogle Scholar
• Barlow J J, DiCioccio R A, Dillard P. frequency of an allele for low activity of a-L-fucosidase in sera: Possible increase in epithelial ovarian cancer patients. J Natl Cancer Inst 1981; 67: 1005–1009
   PubMed Web of Science ®Google Scholar
• Feig L A, Bast R C, Knapp R C. Somatic acivation of rasK gene in a human ovarian carcinoma. Science 1984; 223: 688–701
   Google Scholar
• Filmus J E, Buick R N. Stability of c-K-rar amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res 1985; 46: 4465–4472
   Google Scholar
• Fukumoto M, Estensen R D, Sha L. Association of Ki-ras widi amplified DNA sequences detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res 1989; 49: 1693–1697
   PubMed Web of Science ®Google Scholar
• Enomoto T, Inoue M, Perantoni A O. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 1990; 50: 6139–6145
   PubMed Web of Science ®Google Scholar
• Filmus J, Trent J M, Pullano R. A cell line from a human ovarian carcinoma with amplification of the K-ras gene. Cancer Res 1986; 46: 5179–5182
   PubMed Web of Science ®Google Scholar
• Zhou D J, Gonzalez-Cadavid N, Ahuja H. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinoma. Cancer 1988; 62: 1573–1576
   PubMed Web of Science ®Google Scholar
• O'Brien T J, Bannon G A, Bard D S. Expression of the ras oncogene in gynecologic tumors. Am J Obstet Gynecol 1989; 0: 344–352
   Google Scholar
• Rodenburg C J, Koelma I A, Nap N. Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome. Arch Pathol Lab Med 1988; 112: 151–154
   PubMed Web of Science ®Google Scholar
• Slamon D J, DeKernion J B, Verma I M. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Sasano H, Garrett C T, Wilkinson D S. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. Human Pathol 1990; 21: 382–391
   PubMed Web of Science ®Google Scholar
• Schreiber G, Dubeau L. C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am J Pathol 1990; 137: 653–658
   PubMed Web of Science ®Google Scholar
• Yasue H, Takeda A, Ishibashi M. Amplification of the c-myc gene and the elevation of its transcripts in human ovarian tumor lines. Cell Struct Func 1987; 12: 121–125
   PubMed Web of Science ®Google Scholar
• Kohler M, Janzl, Wintzer H O. The expression of EGF receptors, EGF-like factor and cy-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 1989; 9: 1537–1548
   PubMed Web of Science ®Google Scholar
• Polacarz S V, Hey N A, Stephenson T J. C-myc oncogene product P62cmc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy. J Clin Pathol 1989; 42: 148–152
   PubMed Web of Science ®Google Scholar
• Watson J V, Curling O M, Munn C F. Oncogene expression in ovarian cancer: A pilot study of c-myc oncoprotein in serous papillary ovarian cancer. Gynecol Oncol 1987; 28: 137–150
   PubMed Web of Science ®Google Scholar
• Kacinski B M, Carter D, Kohorn E I. Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors. Yale J Biol Med 1989; 62: 379–392
   PubMed Web of Science ®Google Scholar
• Slamon D J, Godolphin W, Jones L A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712
   PubMed Web of Science ®Google Scholar
• Berchuk A, Kamel A, Whitaker R. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990; 50: 4087–4091
   PubMed Web of Science ®Google Scholar
• Marth C, Muller-Holzner E, Greter E. 7-Interferon reduces expression of the protooncogene c-erb2 in human ovarian carcinoma cells. Cancer Res 1990; 50: 7037–7041
   PubMed Web of Science ®Google Scholar
• Lichtenstein A, Berenson J, Gera J F. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: Correlation of expression of HER2/neu oncogenes. Cancer Res 1990; 50: 7364–7370
   PubMed Web of Science ®Google Scholar
• Haldane J S, Hird V, Hughes C M. C-erb B-2 oncogene expression in ovarian cancer. J Pathol 1990; 162: 231–237
   PubMed Web of Science ®Google Scholar
• Krontiris T G, DiMartiro N A, Colb M. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients. Nature 1985; 313: 369–374
   PubMed Web of Science ®Google Scholar
• Corell B, Zoll B. Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast and ovarian cancer. Human Genet 1988; 79: 255–259
   PubMed Web of Science ®Google Scholar